Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
Objective: Genetic and acquired abnormalities contribute to pancreatic β-cell failure in diabetes. Transcription factors Hnf4α (MODY1) and FoxO1 are respective examples of these two components and act through β-cell-specific enhancers. However, their relationship is unclear. Methods: In this report,...
Main Authors: | Taiyi Kuo, Wen Du, Yasutaka Miyachi, Prasanna K. Dadi, David A. Jacobson, Daniel Segrè, Domenico Accili |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877821001010 |
Similar Items
-
HNF1A Mutations and Beta Cell Dysfunction in Diabetes
by: Yasutaka Miyachi, et al.
Published: (2022-03-01) -
Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
by: Takumi Kitamoto, et al.
Published: (2022-12-01) -
Compensatory mutations cause excess of antagonistic epistasis in RNA secondary structure folding
by: Adami Christoph, et al.
Published: (2003-02-01) -
FoxO1 Is a Novel Regulator of 20S Proteasome Subunits Expression and Activity
by: Marianna Kapetanou, et al.
Published: (2021-02-01) -
Exploring the Genetic Conception of Obesity via the Dual Role of FoxO
by: Tapan Behl, et al.
Published: (2021-03-01)